SCHEMBL19863961

SCHEMBL19863961

Cc1ccc(-c2nc(-c3ccccc3)nc(-c3ccc4c(c3)-c3ccccc3C43c4ccccc4C=Cc4ccccc43)n2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 4/20 0.38
▸ NPC1 O15118 5/20 0.38
▸ RAB9A P51151 5/20 0.38
▸ ALDH1A1 P00352 3/20 0.38
▸ NFKB1 P19838 3/20 0.38
▸ NFKB2 Q00653 3/20 0.38
▸ RELA Q04206 3/20 0.38
▸ MEN1 O00255 4/20 0.37
▸ KMT2A Q03164 4/20 0.37
▸ MAPT P10636 3/20 0.37
▸ HPGD P15428 3/20 0.37
▸ NR1H2 P55055 1/20 0.37
▸ NR1H3 Q13133 1/20 0.37
▸ GBA1 P04062 1/20 0.36
▸ PDK2 Q15119 2/20 0.36
▸ AGTR1 P30556 1/20 0.36
▸ TP53 P04637 2/20 0.36
▸ LMNA P02545 1/20 0.36
▸ ABCG2 Q9UNQ0 1/20 0.36
▸ DPP4 P27487 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19863798 0.95 MEN1 (0.41) L3MBTL1NPC1RAB9AALDH1A1MEN1
SCHEMBL19863819 0.93 MEN1 (0.40) L3MBTL1NPC1RAB9AALDH1A1MEN1
SCHEMBL21923480 0.91 PDK2 (0.42) L3MBTL1NPC1RAB9AALDH1A1NFKB1
SCHEMBL19863849 0.90 MEN1 (0.37) L3MBTL1NPC1RAB9AALDH1A1MEN1
SCHEMBL19863821 0.90 MEN1 (0.37) L3MBTL1ALDH1A1MEN1KMT2AMAPT
SCHEMBL19863797 0.88 PDK2 (0.36) L3MBTL1NPC1RAB9AALDH1A1MEN1
SCHEMBL19871580 0.87 L3MBTL1 (0.38) L3MBTL1NPC1RAB9AALDH1A1NFKB1
SCHEMBL19863861 0.87 MEN1 (0.45) L3MBTL1ALDH1A1MEN1KMT2AMAPT
SCHEMBL19863823 0.87 MEN1 (0.41) L3MBTL1ALDH1A1MEN1KMT2AMAPT
SCHEMBL19863881 0.87 MEN1 (0.41) L3MBTL1ALDH1A1MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180047908-A1 COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME NICHEM FINE TECHNOLOGY CO., LTD. (TW) 2018-02-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180047908-A1 COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME ESR1, AOC2, PIEZO1 L3MBTL1 1194/4885NPC1 1812/4885RAB9A 2614/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback